ERBB2 and breast cancer: Groheux et al. found that SUVmax and TLG varied among breast different phenotypes (Her-2-positive, ER-positive/ HER-2-negative and triple negative) but none of the PET metrics provided high accuracy in distinguishing between prognostic subtypes of breast cancers (25).